These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH, Yee R, Jung W. J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117 [Abstract] [Full Text] [Related]
3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ. Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [Abstract] [Full Text] [Related]
4. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group. Baker JH, Epstein AE, Voshage-Stahl L. Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974 [Abstract] [Full Text] [Related]
6. [Results and experiences of transvenous endocardial defibrillator therapy]. Trappe HJ, Fieguth HG, Weber-Conrad O, Schöhl W, Wahlers T, Kielblock B, Wenzlaff P, Klein H, Lichtlen PR. Med Klin (Munich); 1992 Dec 15; 87(12):615-21. PubMed ID: 1287422 [Abstract] [Full Text] [Related]
7. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation. Yee R, Klein GJ, Leitch JW, Guiraudon GM, Guiraudon CM, Jones DL, Norris C. Circulation; 1992 Jan 15; 85(1):196-204. PubMed ID: 1728450 [Abstract] [Full Text] [Related]
8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
12. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Bardy GH, Dolack GL, Kudenchuk PJ, Poole JE, Mehra R, Johnson G. Circulation; 1994 Mar 08; 89(3):1090-3. PubMed ID: 8124794 [Abstract] [Full Text] [Related]
15. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Serafrica M, Sosa Liprandi A. Pacing Clin Electrophysiol; 1995 Jan 08; 18(1 Pt 2):133-6. PubMed ID: 7724386 [Abstract] [Full Text] [Related]